Camp4 (Series B)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Funding URL
View Funding Page
Valuation
$277,672,632
Company Info
Founders
Josh Mandel-Brehm
Market
Healthcare & Wellness
Coinvestors
5AM Ventures,The Kraft Group,Patient Square Capital,Northpond Ventures,Polaris,Andreessen Horowitz
Company Description

Camp4 is developing a novel approach to upregulate the expression of genes using regulatory RNA to create treatments for hundreds of diseases caused by faulty gene expression. CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.

Links
WebsiteCrunchbaseLinkedInTwitter
Back to HomeBack to Healthcare and Biotech DealsView Funding Announcement